HG
ABBV icon

Harbor Group’s AbbVie ABBV Stock Holding History

Harbor Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Sell
1,276
-138
-10% -$29.7K 0.04% 90
2026
Q1 		$307K Sell
1,414
-36
-2% -$7.99K 0.04% 87
2025
Q4 		$331K Sell
1,450
-24
-2% -$5.47K 0.05% 84
2025
Q3 		$341K Sell
1,474
-41
-3% -$8.35K 0.05% 79
2025
Q2 		$281K Hold
1,515
– – 0.05% 82
2025
Q1 		$317K Sell
1,515
-50
-3% -$9.72K 0.06% 72
2024
Q4 		$278K Buy
1,565
+25
+2% +$4.6K 0.06% 73
2024
Q3 		$304K Hold
1,540
– – 0.07% 67
2024
Q2 		$264K Buy
1,540
+10
+0.7% +$1.66K 0.07% 68
2024
Q1 		$279K Hold
1,530
– – 0.07% 62
2023
Q4 		$237K Sell
1,530
-152
-9% -$22.2K 0.07% 67
2023
Q3 		$251K Hold
1,682
– – 0.14% 55
2023
Q2 		$227K Buy
1,682
+10
+0.6% +$1.47K 0.13% 56
2023
Q1 		$266K Buy
1,672
+15
+0.9% +$2.29K 0.16% 51
2022
Q4 		$268K Buy
+1,657
New +$254K 0.17% 46

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harbor Group's ABBV Position: Q2 2026 in Review

Harbor Group reduced its AbbVie (ABBV) stake by 9.8% in Q2 2026, selling an estimated $29.7K and leaving 1,276 shares worth $321K. The position accounts for 0.04% of the portfolio, ranked #90.

Harbor Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $341K in Q3 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harbor Group held 1,276 shares of AbbVie worth $321K as of Q2 2026.
  • Harbor Group sold 138 AbbVie shares in Q2 2026, an estimated $29.7K.
  • AbbVie made up 0.04% of Harbor Group's portfolio in Q2 2026, its #90 holding.
  • Harbor Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • Harbor Group's AbbVie position peaked at $341K in Q3 2025.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harbor Group's 13F filing for Q2 2026, filed 22 Jul 2026.